Several FDA-Approved Drugs Effectively Inhibit SARS-CoV-2 Infection in vitro

被引：19
|
作者：
Xiong, Hua-Long [1 ,2 ]
Cao, Jia-Li [1 ,2 ,3 ]
Shen, Chen-Guang [4 ,5 ]
Ma, Jian [1 ,2 ]
Qiao, Xiao-Yang [1 ,2 ]
Shi, Tian-Shu [1 ,2 ]
Ge, Sheng-Xiang [1 ,2 ]
Ye, Hui-Ming [2 ,3 ]
Zhang, Jun [1 ,2 ]
Yuan, Quan [1 ,2 ]
Zhang, Tian-Ying [1 ,2 ]
Xia, Ning-Shao [1 ,2 ]
机构：
[1] Xiamen Univ, Natl Inst Diagnost & Vaccine Dev Infect Dis, Sch Life Sci, State Key Lab Mol Vaccinol & Mol Diagnost, Xiamen, Peoples R China
[2] Xiamen Univ, Sch Publ Hlth, Xiamen, Peoples R China
[3] Xiamen Univ, Sch Med, Women & Childrens Hosp, Dept Clin Lab, Xiamen, Peoples R China
[4] Southern Univ Sci & Technol, State Key Discipline Infect Dis, Hosp Affiliated 2,Shenzhen Peoples Hosp 3, Shenzhen Key Lab Pathogen & Immun,Natl Clin Res C, Shenzhen, Peoples R China
[5] Southern Med Univ, Sch Publ Hlth, Guangzhou, Peoples R China
来源：
FRONTIERS IN PHARMACOLOGY | 2021年 / 11卷
基金：
中国国家自然科学基金;
关键词：
drug screening; SARS-CoV-2; pseudovirus assay; vesicular stomatitis virus; drug combination; ENTRY;
D O I：
10.3389/fphar.2020.609592
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
To identify drugs that are potentially used for the treatment of COVID-19, the potency of 1403 FDA-approved drugs were evaluated using a robust pseudovirus assay and the candidates were further confirmed by authentic SARS-CoV-2 assay. Four compounds, Clomiphene (citrate), Vortioxetine, Vortioxetine (hydrobromide) and Asenapine (hydrochloride), showed potent inhibitory effects in both pseudovirus and authentic virus assay. The combination of Clomiphene (citrate), Vortioxetine and Asenapine (hydrochloride) is much more potent than used alone, with IC50 of 0.34 mu M.
引用
收藏
页数：8
相关论文
共 50 条
  • [1] Antiviral Efficacies of FDA-Approved Drugs against SARS-CoV-2 Infection in Ferrets
    Park, Su-Jin
    Yu, Kwang-Min
    Kim, Young-Il
    Kim, Se-Mi
    Kim, Eun-Ha
    Kim, Seong-Gyu
    Kim, Eun Ji
    Casel, Mark Anthony B.
    Rollon, Rare
    Jang, Seung-Gyu
    Lee, Min-Hyeok
    Chang, Jae-Hyung
    Song, Min-Suk
    Jeong, Hye Won
    Choi, Younho
    Chen, Weiqiang
    Shin, Woo-Jin
    Jung, Jae U.
    Choi, Young Ki
    [J]. MBIO, 2020, 11 (03):
  • [2] Remdesivir and Ledipasvir among the FDA-Approved Antiviral Drugs Have Potential to Inhibit SARS-CoV-2 Replication
    Pirzada, Rameez Hassan
    Haseeb, Muhammad
    Batool, Maria
    Kim, MoonSuk
    Choi, Sangdun
    [J]. CELLS, 2021, 10 (05)
  • [3] The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
    Caly, Leon
    Druce, Julian D.
    Catton, Mike G.
    Jans, David A.
    Wagstaff, Kylie M.
    [J]. ANTIVIRAL RESEARCH, 2020, 178
  • [4] Repurposing Screens of FDA-Approved Drugs Identify 29 Inhibitors of SARS-CoV-2
    Ku, Keun Bon
    Shin, Hye Jin
    Kim, Hae Soo
    Kim, Bum-Tae
    Kim, Seong-Jun
    Kim, Chonsaeng
    [J]. JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, 2020, 30 (12) : 1843 - 1853
  • [5] Potential SARS-CoV-2 protease Mpro inhibitors: repurposing FDA-approved drugs
    Kouznetsova, Valentina L.
    Huang, David Z.
    Tsigelny, Igor F.
    [J]. PHYSICAL BIOLOGY, 2021, 18 (02)
  • [6] Identification and Assessment of FDA-Approved Drugs for Repurposing as Single and Combination Therapies Against SARS-CoV-2 Infection
    Pacl, H. T.
    Tipper, J. L.
    Holder, G. D.
    Sevalkar, R. R.
    Nadeem, S.
    Chinta, K. C.
    Crouse, A.
    Steyn, A. J. C.
    Might, M.
    Harrod, K. S.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [7] Repurposing FDA-approved drugs against multiple proteins of SARS-CoV-2: An in silico study
    Akinlalu, Alfred Olaoluwa
    Chamundi, Annapoorna
    Yakumbur, Donald Terseer
    Afolayan, Funmilayo I. Deborah
    Duru, Ijeoma Akunna
    Arowosegbe, Michael Aderibigbe
    Enejoh, Ojochenemi Aladi
    [J]. SCIENTIFIC AFRICAN, 2021, 13
  • [8] Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs
    Jeon, Sangeun
    Ko, Meehyun
    Lee, Jihye
    Choi, Inhee
    Byun, Soo Young
    Park, Soonju
    Shum, David
    Kim, Seungtaek
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (07)
  • [9] Repurposing FDA-Approved Drugs as Potential Inhibitors of SARS-CoV-2 PLpro: A Comprehensive Computational Study
    Metwaly, Ahmed M.
    Elkaeed, Eslam B.
    Alsfouk, Aisha A.
    Ibrahim, Ibrahim M.
    Soliman, Omar A.
    Elkady, Hazem
    Eissa, Ibrahim H.
    [J]. JOURNAL OF COMPUTATIONAL BIOPHYSICS AND CHEMISTRY, 2024, 23 (09): : 1209 - 1231
  • [10] Sulfated polysaccharides effectively inhibit SARS-CoV-2 in vitro
    Paul S. Kwon
    Hanseul Oh
    Seok-Joon Kwon
    Weihua Jin
    Fuming Zhang
    Keith Fraser
    Jung Joo Hong
    Robert J. Linhardt
    Jonathan S. Dordick
    [J]. Cell Discovery, 6
12345